TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.
Clinical trial NCT04498481 · COMPLETED
Trial details
- NCT number
- NCT04498481
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-07-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.